Treatment with single tablet sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for 12 weeks "is a highly effective salvage therapy" for patients who did not ...
Patient-reported outcome scores improve significantly for HIV-HCV co-infected patients undergoing sofosbuvir and velpatasvir therapy. BOSTON, MA—A fixed-dose combination of the sofosbuvir (SOF) and ...
While there were no discontinuations from SOF/VEL/VOX treatment due to adverse events, three patients discontinued ribavirin due to anemia, fatigue or rash. “This study is limited by its relatively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results